Hypertension and Antiangiogenesis The Janus Face of VEGF Inhibitors ∗

Overview of attention for article published in JACC: CardioOncology, September 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)

Mentioned by

news: 1 news outlet

twitter: 4 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 13 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

Adverse Effects Impact Treatment Selection for VEGF-Targeted Oral TKIs in Metastatic RCC

Pharmacy Times, 13 Dec 2023

Kidney and renal pelvic cancers are among the top 10 most common cancers in the United States, with an estimated 79,000 new…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.